Arteriosclerosis, an arteriitis caused by Chlamydia pneumoniae;Arteriosklerose - eine Infektion durch Chlamydia pneumoniae

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 36, 1997, Pages 1086-1091

  Stille, W ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; QUINOLONE; TETRACYCLINE;

ARTERIOSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; DRUG EFFECT; HUMAN; REVIEW; RISK FACTOR;

EID: 0030818104     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1233726     Document Type: Review

References (50)

1. Allegra, L., F. Blasi (Ed.): Chlamydia pneumoniae Infection. (Springer: Milano 1995), 90.
2. Benditt, E. P., J. M. Benditt: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. nat. Acad. Sci. 70 (1973), 1753-1759.
3. Blasi, F., F. Denti, M. Erba, R. Cosentini, R. Raccanelli, A. Rinaldi, L. Fragetti, G. Esposito, U. Ruberti, L. Allegra: Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J. clin. Microbiol. 34 (1996), 2766-2769.
4. Campbell, L. A., E. R. O'Brien, A. L. Cappuccio, C. C. Kuo, S. R. Wang, D. Stewart, D. L. Patton, P. K. Cummings, J. T. Grayston: Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172 (1995), 585-588.
5. Cook, P. J., D. Honeybourne: Chlamydia pneumoniae. J. Antimicrob. Chemother. 34 (1994), 859-873.
6. Dahlen, G. H., J. Boman, L. S. Birgander, B. Lindblom: Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 114 (1995), 165-174.
7. Enzler, M. J., T. F. Smith, M. Espy, T. Felmlee, J. Rumberger, M. S. Rous, W. D. Edwards, J. Steckelberg: Inability to detect Chlamydia pneumoniae (TWAR) in human autopsy coronary arteries (CA) by polymerase chain reaction (PCR) 35th Interscience Congress of Antimicrobial Agents and Chemotherapy (San Francisco: 1995), Abstract LM81.
8. Fong, I. W., B. Chiu, E. Viira, M. Fong, D. Jang, J. Mahony: Rabbit model for Chlamydia pneumoniae infection. J. clin. Microbiol. 35 (1997), 48-52.
9. Forsey, T., S. Darouger, J. D. Treharne, B. R. Jones, A. J. Herring: Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of Chlamydia. J. Infect. 12 (1986), 145-152.
10. Gaydos, C. A., J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn: Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. and Immun. 64 (1996), 1614-1620.
11. Godzik, K. L., E. R. O'Brien, S. K. Wang, C. C. Kuo: In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. clin. Microbiol. 33 (1995), 2411-2414.
12. Gounaris, T. H., E. Sioula, M. Anagnostopoulou, P. Spirou, M. Zouroudis, G. Kouskos, L. Flessas, O. Pniara, G. Saroglou: Chlamydia pneumoniae (CP) antibodies in patients with acute myocardial infarction (AMI). 35th Interscience Congress of Antimicrobial Agents and Chemotherapy (San Francisco: 1995), Abstract LM75.
13. Grayston, J. T., C. C. Kuo, S. P. Wang, J. Altmann: A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection. New Engl. J. Med. 315 (1986), 161-168.
14. Grayston, J. T., C. C. Kuo, L. A. Campbell, S. P. Wang: Proposal to create the Chlamydia pneumoniae sp. nov. for Chlamydia TWAR. Intern. J. System. Bacteriol. 39 (1989), 88-90.
15. Grayston, J. T., C. C. Kuo, L. A. Campbell, E. P. Benditt: Chlamydia pneumoniae, strain TWAR and atherosclerosis. Europ. Heart J. 14 (Suppl. K) (1993), 66-71.
16. Grayston, J. T., C. C. Kuo, A. S. Coulson, L. A. Campbell, R. D. Lawrence, M. J. Lee, E. D. Strandness, S. P. Wang: Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92 (1995), 3397-3400.
17. Grimm, R. H., J. D. Neaton, W. Ludwig for the Multiple Risk Factor Intervention Trial Group: Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. J. Amer. med. Ass. 254 (1985), 1932-1937.
18. Gupta, S., E. W. Leatham, D. Carrington, M. Mendall, N. Ireson, J. Tooze, D. Bevan, A. J. Camm, J. C. Kaski: The effect of azithromycin in post-myocardial infarction (MI) patients with elevated Chlamydia pneumoniae antibody titres. Amer. Coll. Cardiol. 46th Annual Scientific Session (Anaheim, California: 1997).
19. Hahn, D. L., P. Saikku: Chlamydia, smoking and heart disease. Ann. int. Med. 117 (1992), 71.
20. Hahn, D. L., R. Golubjanikow: Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler. Thromb. 12 (1992), 945-947.
21. Kuller, L. H., R. P.Tracy, J. Shaten, E. N. Meilan: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control-study. Amer. J. Epidemiol. 144 (1996), 537-547.
22. Kuo, C. C., J. T. Grayston, L. A. Campbell, Y. A. Goo, R. W. Wissler, E. P. Benditt: Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. nat. Acad. Sci. 92 (1995), 6911-6914.
23. Linnanmäki, E., M. Leinonen, K. Mattila, M. S. Nieminen, V. Valtonen, P. Saikku: Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87 (1993), 1130-1134.
24. Liuzzo, G., L. M. Biasucci, J. R. Gallimore, R. L. Grillo, A. G. Rebuzzi, M. B. Pepys, A. Maseri: The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. New Engl. J. Med. 331 (1994), 412-424.
25. Maass, M., J. Gieffers: Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol. Infect. Dis. 6 (1996), 65-70.
26. Maass, M.: Chlamydia pneumoniae in der Ätiologie respiratorischer und vaskulärer Erkrankungen des Menschen. Habilitationsschrift (Lübeck: 1996).
27. Meade, T. W.: Fibrinogen and cardiovascular disease. J. clin. Pathol. 50 (1997), 13-15.
28. Melnick, S. L., E. Shahar, A. R. Folsom, J. T. Grayston, P. D. Sorlie, S. P. Wang, M. Szklo: Past infection by Chlamydia pneumoniae strains TWAR and asymptomatic carotid atherosclerosis. Amer. J. Med. 95 (1993), 499-445.
29. Mendall, M. A., D. Carrington, D. Strachan, P. Patel, N. Molineaux, J. Levi, T. Toosey, A. J. Camm, T. C. Northfield: Chlamydia pneumoniae risk factors for seropositivity and association with coronary heart disease. J. Infect. 30 (1995), 121-128.
30. Miettinen, H., S. Lehto, P. Saikku, S. M. Haffner, T. Rönnemaa, K. Pyörälä, M. Laasko: Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Europ. Heart J. 17 (1996), 682-88.
31. Muhlestein, J. B., E. H. Hammond, J. F. Carlquist, E. Radicke, M. J. Thomson, C. A. Karagounis, M. L. Woods, J. L. Anderson: Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J. Amer. Coll. Cardiol. 27 (1996), 1555-1561.
32. Ong, G., B. J. Thomas, A. O. Mansfield, B. R. Davidson, D. Taylor-Robinson: Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J. clin. Pathol. 49 (1996), 102-106.
33. Ouchi, K., B. Fujii, Y. Kanamoto, H. Miyazaki, T. Nakazawa: Detection of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries and large arteries. 35th Interscience Congress of Antimicrobial Agents and Chemotherapy (San Francisco: 1995), Abstract K37.
34. Paltiel, O., J. D. Kark, M. Leinonnen, P. Saikku: High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents. Epidemiol. Infect. 114 (1995), 465-473.
35. Patel, P., D. Carrington, D. P. Strachan, E. Leatham, P. Goggin, T. C. Northfield, M. A. Mendall: Fibrinogen. A link between chronic infection and coronary heart disease. Lancet 343 (1994), 1634-1635.
36. Puolakkainen, M., C. C. Kuo, A. Shor, S. P. Wang, J. T. Grayston, L. A. Campbell: Serological response to Chamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J. clin. Microbiol. 31 (1993), 2212-2214.
37. Ramirez, J. A. and the Chlamydia pneumonaiae/Atherosclerosis Study Group: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. intern. Med. 125 (1996), 979-982.
38. Ross, R.: The pathogenesis of atherosclerosis. A perspective of the 1990s. Nature 362 (1993), 801-809.
39. Saikku, P., M. Leinonen, E. Linnanmöki, K. Mattila, M. S. Nieminen, V. Valtonen: Association of immune complexes containing chlamydial lipopolysaccharied with coronary heart disease. In Bowie W. R., H. D. Caldwell, R. P. Jones, P.-A. Mardh, G. L. Ridgway, J. Schachter (Ed.): Chlamydial Infections (Cambridge University Press: Cambridge 1990), 449-452.
40. Saikku, P., K. Mattila, M. S. Nieminen, J. K. Huttunen, M. Leinonen, M.-R. Ekmann, P. H. Mäkela, V. Valtonen: Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 29 (1988), 983-984.
41. Saikku, P., S. O. Wang, M. Kleemola, E. Brander, E. Rusanen, J. T. Grayston: An epidemic of mild pneumoniaia due to an unusual strain of Chlamydia psittaci. J. Infect. Dis. 151 (1985), 832-839.
42. Saikku, P.: Chlamydia TWAR and its epidemiology. In Proceedings of the First Conference of the European Society of Chlamydial Research (Almquist & Wiksell International: Stockholm 1988), 7-10.
43. Saikku, P.: The epidemiology and significance of Chlamydia pneumoniae. J. Infect. 25 (Suppl. 1) (1992), 27-34.
44. Shor, A., C. C. Kuo, D. L. Patton: Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaque. S. Afr. med. J. 82 (1992), 158-161.
45. Sutter, M. C.: Lessons for atherosclerosis research from tuberculosis and peptic ulcer. Canad. med. Ass. J. 152 (1995), 667-670.
46. Thom, D. H., J. T. Grayston, D. S. Siscovick, S.-P. Wang, N. S. Weiss, J. R. Daling: Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease. J. Amer. med. Ass. 268 (1992), 68-72.
47. Thom, D. H., S. P. Wang, D. K. Steward, J. T. Grayston: Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. In Bowie W. R., H. D. Caldwell, R. P. Jones, P.-A. Mardh, G. L. Ridgway, J. Schachter (eds.): Chlamydia Infections (Cambridge University Press: Cambridge 1990) 453-456.
48. Weiss, S. M., P. M. Boblin, C. A. Gaydos, P. Cumming, D. L. Patton, N. Schulhoff, J. Shani, R. Frankel, K. Penney, T. C. Quinn, M. R. Hammerschlag: Failure to detect chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J. Infect. Dis. 173 (1996), 957-962.
49. Wesslén, L., C. Pahlson, O. Lindquist, E. Hjelm, J. Gnarpe, L. E. Larsson, U. Baandrup, L. Eriksson, J. Fohlman, L. Engstrand, T. Linglöf, C. Nyström-Rosander, H. Gnarpes, L. Magnius, C. Rolf, G. Friman: An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Europ. Heart J. 17 (1996), 902-910.
50. Yarnell, J. W. G., I. A. Baker, P. M. Sweetnam, D. Bainton, J. R. O'Brien, P. J. Whitehead, P. C. Elwood: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Cearplhilly and Speedwell Heart Disease Studies. Circulation 83 (1991), 836-844.